Back to MW MARSHALL WACE, LLP

AMLXAMLX
13 quarters

Position history for MWMARSHALL WACE, LLP's holdings in AMYLYX PHARMACEUTICALS INC

MARSHALL WACE, LLP previously held 0 shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$7.5M

Total Shares Change

-584,464

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$6.33
0
2025-Q1
Increased
247,275
+33.9%
$875,3530.0%$3.66
32
2024-Q4
Decreased
184,678
-35.0%
$698,0830.0%$3.84
0
2024-Q3
New
283,986
-
$920,1140.0%$3.08
35
2024-Q1
Exited
0
-100.0%
$00.0%$2.84
0
2023-Q4
Decreased
985,114
-17.8%
$14.5M0.0%$14.72
0
2023-Q3
Decreased
1.2M
-39.5%
$21.9M0.0%$18.31
0
2023-Q2
Increased
2M
+73.8%
$42.7M0.1%$20.98
44
2023-Q1
New
1.1M
-
$33.4M0.1%$27.71
40
2022-Q4
Exited
0
-100.0%
$00.0%$36.95
0
2022-Q3
Decreased
341,064
-48.2%
$9.6M0.0%$30.19
0
2022-Q2
Increased
658,373
+12.7%
$12.7M0.0%$18.18
31
2022-Q1
New
584,464
-
$7.5M0.0%$14.93
38

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used